<?xml version="1.0" encoding="UTF-8"?>
<p>COVID-19 can be diagnosed by either chest CT radiography or a laboratory testing. Unfortunately, specific antiviral drugs or vaccines currently have not been available for the treatment 
 <xref rid="B10" ref-type="bibr">10</xref>, 
 <xref rid="B11" ref-type="bibr">11</xref>. According to the current clinical guideline in China and the experiences in the treatment of SARS or Middle East Respiratory Syndrome (MERS) patients, both conventional medicine and traditional Chinese medicine (TCM) are used for the treatment of patients with infection of SARS-CoV-2 in China 
 <xref rid="B12" ref-type="bibr">12</xref>-
 <xref rid="B14" ref-type="bibr">14</xref>. This review mainly focuses on the discussion of TCM usage in the treatment of COVID-19 patients, in the context of current conventional management. Due to the homology in epidemiology, genomics, and pathogenesis of the SARS-CoV-2 and SARS-CoV 
 <xref rid="B8" ref-type="bibr">8</xref>, 
 <xref rid="B9" ref-type="bibr">9</xref>, and widely usage of TCM in the treatment of patients infected with SARS-CoV in 2002-2003 
 <xref rid="B15" ref-type="bibr">15</xref>, the clinical evidence showing the efficacy and safety of TCM in the treatment of patients with the emerging coronaviral will be summarized and analyzed, including the laboratory studies that provide an insight into molecular basis of therapeutic benefits.
</p>
